Literature DB >> 15040519

Prevalence of HIV among women with vaginal discharge in a gynecological clinic.

Rose Anorlu1, Donald Imosemi, Nkiru Odunukwe, Olalekan Abudu, Mirable Otuonye.   

Abstract

OBJECTIVE: Vaginal discharge is a common complaint among women with sexually transmitted diseases (STDs) in Nigeria. Given the association between STDs and HIV and the alarming rise in the prevalence of HIV in Nigeria, we performed this study to determine the prevalence of HIV in patients with vaginal discharge. STUDY
DESIGN: Between April 2000 and August 2000, women who attended the Lagos University Teaching Hospital and complained of vaginal discharge were adequately counseled for HIV serotest. High vaginal/endocervical swabs and venous blood were taken for microbiological studies and HIV serotest, respectively.
RESULTS: Out of the 230 women counseled for HIV serotest 140 (60.9%) consented. The mean age of the 140 was 31.1+/-6.9 years (range 18-50 years). In 31 (22.1%), Candida albicans was isolated, in 26 Gardnerella vaginalis (18.8%), in 17 Staphylococcal spp. (12.1%); and E. coli, Trichomonas vaginalis, and Neisseria gonococcus in 7.9%, 4.3%, and 1.4%, respectively. Four (2.9%) of the 140 patients were HIV seropositive, and all had Candida albicans isolated. The prevalence of HIV among patients with Candida albicans was 12.9%. Association between HIV seropositivity and Candida albicans infection is significant (X2=14.48; p=0.002).
CONCLUSION: Candida albicans is a common cause of vaginal discharge among HIV-seropositive women in Lagos.

Entities:  

Mesh:

Year:  2004        PMID: 15040519      PMCID: PMC2594863     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  12 in total

1.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

Review 2.  Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis.

Authors:  M S Cohen
Journal:  Lancet       Date:  1998       Impact factor: 79.321

3.  Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus.

Authors:  H L Minkoff; D Eisenberger-Matityahu; J Feldman; R Burk; L Clarke
Journal:  Am J Obstet Gynecol       Date:  1999-04       Impact factor: 8.661

Review 4.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.

Authors:  D T Fleming; J N Wasserheit
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

5.  Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases.

Authors:  W C Levine; V Pope; A Bhoomkar; P Tambe; J S Lewis; A A Zaidi; C E Farshy; S Mitchell; D F Talkington
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

6.  Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women.

Authors:  A Duerr; M F Sierra; J Feldman; L M Clarke; I Ehrlich; J DeHovitz
Journal:  Obstet Gynecol       Date:  1997-08       Impact factor: 7.661

7.  Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group.

Authors:  S Cu-Uvin; J W Hogan; D Warren; R S Klein; J Peipert; P Schuman; S Holmberg; J Anderson; E Schoenbaum; D Vlahov; K H Mayer
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

8.  Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya.

Authors:  D B Clemetson; G B Moss; D M Willerford; M Hensel; W Emonyi; K K Holmes; F Plummer; J Ndinya-Achola; P L Roberts; S Hillier
Journal:  JAMA       Date:  1993-06-09       Impact factor: 56.272

9.  Factors associated with vaginal yeast infections in HIV-positive women.

Authors:  A B Williams; S Andrews; K Tashima; J Mezger; C Yu
Journal:  J Assoc Nurses AIDS Care       Date:  1998 Sep-Oct       Impact factor: 1.354

10.  Hierarchical pattern of mucosal candida infections in HIV-seropositive women.

Authors:  N Imam; C C Carpenter; K H Mayer; A Fisher; M Stein; S B Danforth
Journal:  Am J Med       Date:  1990-08       Impact factor: 4.965

View more
  1 in total

1.  Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar.

Authors:  Maria Khan; Jawad Ahmed; Amina Gul; Aamer Ikram; Farida Khurram Lalani
Journal:  Infect Drug Resist       Date:  2018-03-28       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.